Farallon Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $527M | Buy |
|
|||||
|
2025
Q1 | $479M | Buy |
|
|||||
|
2024
Q4 | $579M | Buy |
|
|||||
|
2024
Q3 | $513M | Buy |
|
|||||
|
2024
Q2 | $379M | Buy |
|
|||||
|
2024
Q1 | $242M | Buy |
|
|||||
|
2023
Q4 | $193M | Buy |
|
|||||
|
2023
Q3 | $92M | Buy |
|
|||||
|
2023
Q2 | $74.5M | Sell |
|
|||||
|
2023
Q1 | $71.1M | Buy |
|
|||||
|
2022
Q4 | $40.4M | Sell |
|
|||||
|
2022
Q3 | $49.3M | Sell |
|
|||||
|
2022
Q2 | $63.3M | Hold |
|
|||||
|
2022
Q1 | $82.9M | Buy |
|
|||||
|
2021
Q4 | $69.2M | Hold |
|
|||||
|
2021
Q3 | $75.7M | Buy |
|
|||||
|
2021
Q2 | $79.3M | Buy |
|
|||||
|
2021
Q1 | $73.9M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $454K | Buy |
|